metricas
Medicina Clínica (English Edition) Renal involvement in adults with cystic fibrosis: Study of 89 patients
Journal Information
Vol. 163. Issue 5.
Pages e65-e66 Pages 217-268 (September 2024)
Cite
Cite
Share
Download PDF
More article options
Visits
1102
Vol. 163. Issue 5.
Pages e65-e66 Pages 217-268 (September 2024)
Brief report

Renal involvement in adults with cystic fibrosis: Study of 89 patients

Afectación renal en adultos con fibrosis quística: estudio de 89 pacientes
Visits
1102
Ester Zamarróna,
Corresponding author
Ester.zamarron@gmail.com

Corresponding author.
, Layla Diabb, Jaime Pavóna, Carlos Carpioa, Rodolfo Álvarez-Salaa, María Concepción Pradosa
a Servicio de Neumología, Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain
b Servicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Introduction

We are assisting to an increase in survival rates among individuals with cystic fibrosis (CF). Until now, renal involvement was a minority issue, but with the rise in life expectancy, we will likely see an increase in its prevalence. Our main objective was to assess renal function in CF and study risk factors associated with its deterioration.

Methods

A cross-sectional, retrospective study was conducted, including adults with CF. Clinical, respiratory function, microbiological, blood and urine analysis, and major chronic treatments received were collected.

Results

Eighty nine patients with a mean age of 35 ± 12 years were analyzed. Mean serum creatinine levels were 0.8 ± 0.2 mg/dL. 10.6% had a glomerular filtration rate less than 90 ml/min/1.73 m2. No patient showed albuminuria. In multivariate model, only age was an independent risk factor for reduced glomerular filtration (OR 0.344, 95% CI 0.004−0.017, p = 0.002).

Conclusions

11% of CF adults show decreased glomerular filtration, with age being the sole independent risk factor. Vigilance for this uncommon condition is crucial.

Keywords:
Cystic fibrosis
Renal
Kidney
Life expectancy
Resumen
Introducción

Estamos asistiendo a un progresivo incremento de la supervivencia en la fibrosis quística (FQ). Hasta ahora, la afectación renal era minoritaria, pero con la mejoría de la esperanza de vida, probablemente veremos un aumento de su prevalencia. Nuestro objetivo principal fue evaluar la función renal en FQ y estudiar factores de riesgo asociados a su deterioro.

Métodos

Estudio transversal, retrospectivo en el que se incluyeron adultos con FQ. Se recogieron las características clínicas, de función respiratoria, microbiológicas, análisis de sangre y orina y principales tratamientos crónicos recibidos.

Resultados

Ochenta y nueve pacientes con una edad media de 35 ± 12 años. Los niveles medios de creatinina sérica fueron de 0,8 ± 0,2 mg/dl. El 10,6% tenían un filtrado glomerular menor a 90 ml/min/1,73 m2. Ningún paciente mostró albuminuria. Solo la edad fue factor de riesgo independiente para un filtrado glomerular reducido (OR 0,344, IC95% 0,004–0,017, p = 0,002).

Conclusiones

El 11% de adultos con FQ tienen disminución del filtrado glomerular y la edad es el único factor de riesgo asociado independientemente. Es importante estar alerta de esta entidad hasta ahora poco frecuente.

Palabras clave:
Fibrosis quística
Renal
Riñón
Supervivencia

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
asdasdasd
Article options
Tools